Unicycive Therapeutics, Inc. (UNCY)
5.20
-0.06
(-1.23%)
USD |
NASDAQ |
Aug 31, 16:00
5.22
+0.02
(+0.38%)
After-Hours: 20:00
Unicycive Therapeutics Cash from Operations (Annual) : -31.32M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -31.32M |
| December 31, 2024 | -28.58M |
| December 31, 2023 | -18.28M |
| December 31, 2022 | -15.65M |
| Date | Value |
|---|---|
| December 31, 2021 | -5.767M |
| December 31, 2020 | -1.459M |
| December 31, 2019 | -1.176M |
| December 31, 2018 | -0.775M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 127.04M |
| Theriva Biologics, Inc. | -16.67M |
| AbbVie, Inc. | 19.03B |
| Decoy Therapeutics, Inc. | -4.827M |
| Nkarta, Inc. | -88.70M |